These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 16140741

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.
    He Y, Zhu Q, Liu S, Zhou Y, Yang B, Li J, Jiang S.
    Virology; 2005 Mar 30; 334(1):74-82. PubMed ID: 15749124
    [Abstract] [Full Text] [Related]

  • 5. A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity.
    He Y, Li J, Jiang S.
    Biochem Biophys Res Commun; 2006 May 26; 344(1):106-13. PubMed ID: 16615996
    [Abstract] [Full Text] [Related]

  • 6. Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.
    He Y, Li J, Du L, Yan X, Hu G, Zhou Y, Jiang S.
    Vaccine; 2006 Jun 29; 24(26):5498-508. PubMed ID: 16725238
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
    Zhang H, Wang G, Li J, Nie Y, Shi X, Lian G, Wang W, Yin X, Zhao Y, Qu X, Ding M, Deng H.
    J Virol; 2004 Jul 29; 78(13):6938-45. PubMed ID: 15194770
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants.
    Sui J, Li W, Roberts A, Matthews LJ, Murakami A, Vogel L, Wong SK, Subbarao K, Farzan M, Marasco WA.
    J Virol; 2005 May 29; 79(10):5900-6. PubMed ID: 15857975
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates.
    Li J, Ulitzky L, Silberstein E, Taylor DR, Viscidi R.
    Viral Immunol; 2013 Apr 29; 26(2):126-32. PubMed ID: 23573979
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.
    He Y, Li J, Li W, Lustigman S, Farzan M, Jiang S.
    J Immunol; 2006 May 15; 176(10):6085-92. PubMed ID: 16670317
    [Abstract] [Full Text] [Related]

  • 16. Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
    Chou TH, Wang S, Sakhatskyy PV, Mboudjeka I, Lawrence JM, Huang S, Coley S, Yang B, Li J, Zhu Q, Lu S.
    Virology; 2005 Mar 30; 334(1):134-43. PubMed ID: 15749129
    [Abstract] [Full Text] [Related]

  • 17. Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.
    Callendret B, Lorin V, Charneau P, Marianneau P, Contamin H, Betton JM, van der Werf S, Escriou N.
    Virology; 2007 Jul 05; 363(2):288-302. PubMed ID: 17331558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
    Huang J, Cao Y, Du J, Bu X, Ma R, Wu C.
    Vaccine; 2007 Sep 28; 25(39-40):6981-91. PubMed ID: 17709158
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.